number Done by Corrected by Doctor Hamid Al Zoubi

Size: px
Start display at page:

Download "number Done by Corrected by Doctor Hamid Al Zoubi"

Transcription

1 number 15 Done by أبو عجمي ة مها Corrected by Waseem Abu Obeida Doctor Hamid Al Zoubi

2 In case you don t know - (Bacillus = rod) and (bacilli = rods) - hypersensitivity tests can be either immediate (within few hours or less) or delayed, in this sheet, we are discussing the delayed test. - Dormant (from the verb dormir which means sleep) - Focus = many foci & bacterium = many bacteria Mycobacteria: Mycobacteria tuberculosis. Mycobacteria leprae. Mycobacteria tuberculosis Mycobacterium tuberculosis (M. tuberculosis) is a strict aerobic bacillus. It affects 50% of people worldwide (about 2 billions). It causes death to 3 million (Tuberculosis (TB) increases, when immunity responses are lowered as a result of chemotherapy and HIV infections). MDR (multi-drug resistant tuberculosis) is one of the problems, we are facing today. The M. tuberculosis complex are human pathogens that cause tuberculosis, the complex includes: Notes: 1. M. tuberculosis 2. M. africanum 3. M. bovis 4. M. canettii M. canetti has smooth colonies but M. tuberculosis has rough colonies. The mycobacteria are characterized by thick lipid-rich cell walls (thick mycolic acid), this is why they are stained by acid-fast / ziehl neelson stains, so we don t use gram stains because of their hydrophobicity. mycobacteria are characterized by acid-fast staining property. Most of them are strict aerobic acid-fast bacilli.

3 They are killed by UV, Alcohol, many types of aldehydes, they are also destroyed by pasteurization (heat sensitive). They are resistant to alkalis, acids and ammonia. Growth Media -Löwenstein Jensen (LJ) medium is an egg glycerol-based medium to which malachite green dye is added to inhibit the growth of other bacteria (other than mycobacteria) and to provide a contrasting colour against which colonies of mycobacteria are easily seen. (something like a background) -Liquid medium, enriched with bovine serum albumin. Note: Liquid medium is more rapid (takes about 10 days) but Löwenstein Jensen (LJ) is slow, it takes more time (6-8 weeks), because the bacterium that causes TB is slow growing. Pathogenesis: (commonly in lungs) ( immune response by CD4 T helper cells) If a malnourished patient from a poor environment, with fever (rise in his body temperature), weight loss, sweating, think about TB as a possibility. TB vaccines (BCG) are given intradermally (age: 1 st month), some countries don t provide TB injections, why? Because TB tests cannot distinguish active disease from past vaccination, meaning If a person was immunized against TB, the result would be a positive test, because antibodies were produced by vaccines but if the person is not already vaccinated, one option is left, he is latently infected/ have the disease- (bear with me, this will be discussed in more detail in the following pages). What Slides Say: o Lung Primary TB: Macrophages 1 in alveoli > Ghon s focus > To hilar lymph nodes > primary TB complex > PTB attacked by Macrophages 2 (O2 consumption) > surrounding the lesion in granuloma (caseation) > latent Tuberculosis (TB) TB in other places: Skin, intestine and lymph nodes

4 o Post Primary TB 90% of primary infections > latent > reactivation or reinfection > post primary TB Reactivation of primary TB > Post primary TB (Also due to REinfection): Same as in primary but tuberculoma instead of granuloma Spread to LLL, upper airways, bladder, skin (Lopus vulgaris) and bladder (more spread and infectivity) o Secondary and Milliary TB 10% of primary > secondary TB > meningitis, pott s disease, urogenital and skin involvement (s.t milliary TB if opened into a blood vessel > disseminated) crossword puzzle? Let s try to solve it. Note: we wrote what the doctor said, you might find some differences when referring to greenwood or any other source. Initial infection is commonly in the lung, (inhalation of mycobacteria). The alveolar macrophages (Macrophages1) engulf the inhaled bacteria in the alveoli (leading to the formation of Ghon s focus,), Some bacteria are carried to the hilar lymph nodes, then the primary TB complex is formed, then this PTB complex is attacked by another type of macrophages (macrophages 2 :/), these macrophages consumes oxygen decreasing the amounts of O2 reaching the bacteria thus killing it, PTB complex plus macrophages 2 form granuloma and caseation necrosis. (In addition to lungs, Tuberculosis can occur in other places such as skin, intestine and lymph nodes) Then in 90% of patients (with good immune responses), primary infections become latent (dormant foci), then when immunity becomes low for one reason or another, Reactivation of dormant foci of tubercle bacilli or exogenous reinfection leads to post-primary tuberculosis, this leads to post primary TB (reactivated latent), The same process of granuloma formation occurs, but the caseation areas here are called tuberculoma, forming cavities in the lungs and spread to the bronchi,so it will be very infectious and transmitted by coughing,

5 it can also spread to LLL (lower lung loop), upper airways, bladder, skin (Lupus vulgaris) and bladder (more spread and infectivity). What about the remaining 10%? (those who are immunocompromised) Secondary TB arises from the primary TB directly which gives rise to the serious manifestations including meningitis, pott s disease (spine), urogenital and skin involvement. If a focus of infection ruptures into a blood vessel, bacteria are disseminated throughout the body, This, is known as miliary tuberculosis. (it is when bacteria reach the bloodstream, dissemination throughout the body) - Immunocompromised (10%): primary TB> secondry TB>miliary TB (in some cases). - Immunocompetent (90%): primary TB (granuloma)>latent TB>post-primary TB (tuberculoma). Extra note: Infection is different from disease. Infection is producing a focus of organisms (e.g.: bacteria) which may or may not cause tissue damage (i.e, disease), as we said before, when the bacteria (mycobacteria/ tubercle bacilli) remain dormant, the person is infected but does not have the active disease and therefore cannot transmit bacteria to others. In other words, if there was no reactivation of these bacteria or reinfection, the mycobacteria stop at the latent stage and the person will not develop post-primary TB) it is as if these bacteria are kept sleeping. If this person was lucky enough, the bacteria might remain dormant forever. (special thanks to Kumar, Abbas and Aster) Clinically: The following factors increase the likelihood that a patient will have tuberculosis (TB): o HIV infection o History of prior TB treatment (especially if there was no compliance).

6 o TB exposure, Travel to or emigration from a TB endemic area. o Homelessness, shelter-dwelling, incarceration (malnutrition). Symptoms Classic features associated with active TB are as follows: Cough Weight loss/anorexia Fever Night sweats Hemoptysis (coughing up of blood) Chest pain Diagnosis: Diagnosis of post- primary found in upper lung loop :/ (According to Greenwood: For unknown reasons, reactivation or reinfection tuberculosis tends to develop in the upper lobes of the lungs) - Labrotary diagnosis: o Stain: Acid fast stain (Ziehl Neelsen stain) o Culture 6-8 Weeks on LJ less time in liquid medium o Interferon Gamma interferon o PCR (polymerase chain reaction) - History and examination: o Chest x-ray (CXR). o PDD (purified protein derivative) also known as, Mantoux test/ tuberculin test Weeks post infection, an antigenic part of the mycobacteria is injected intradermally, a delayed hypersensitivity in skin occurs 2-3 days after exposure to the antigen whether it is an active infection (that will cause Tuberculosis), vaccine (BCG), environmental mycobacteria (from environment, non-tuberculous mycobacteria).

7 IGRT? interferon gamma release test is promising, though not without problems of specificity, it detects interferon-γ-producing peripheral blood T cells that respond to antigens present only in the bacteria of the active infection. (not environmental or BCG) (to whom it may concern, since we have much time, and we have nothing to do except Micro, The doctor said: read more about IGRT, well, if we found a question in our exam about it, our reference in this course would be anything on Earth but not Greenwood( Back to the PDD test: according to the tuberculin skin test reaction, if the diameter was 5 in immunocompromised people, the result would be a positive test. If the diameter was 15, the result would be positive in any person. (The only thing, the doctor said about this table( Management: Isolation: (isolating a patient in a room to prevent him from transmitting the disease to others outside the room). Combination of medicines, DOTS

8 (DOTS: Directly Observed Treatment Short-course, a strategy to reduce TB cases, in DOTS healthcare workers observe patients as they take their anti- TB medicines, compliance is really important) Treatment: (1st line anti TB) 4 drugs are used for 6 months (first 2 months of REFINA ((rifampicin & isoniazid) +Ethambutol and Pyrazinamide) (the following 4 months, we use only REFINA ((rifampicin & isoniazid))) (2nd line treatment in MDR (multi-drug resistance): Macrolides, Fluroquinilones, aminoglycosides, cycloserine... (3rd line treatment) Linezolid, rifabutin, arginine, vitamin D.. Note: if there was resistance to the first line, second line treatment is used Prevention: by BCG *Bacille Calmette Guérin* it is a life attenuated vaccine, it doesn t kill mycobacteria, it keeps them viable (alive) BCG vaccine has a documented protective effect against meningitis and disseminated TB in children. remember: children s immunity is weak- Mycobacterium leprae stained by Acid fast aerobic Intracellular bacilli

9 similar to M. Tuberculosis (Leprosy bacilli resemble tubercle bacilli in their general morphology) fat in cell wall, M. leprae has a characteristic surface lipid that can be extracted from it. It causes leprosy (Hansen s disease) chronic granulomatous disease principally affecting the skin, mucous membrane, peripheral nervous system and anterior chamber of eyes. The infection often causes severe disfigurement and deformity, it might lead to loss of sensation since peripheral nervous system is affected. Approximately 2 million cases worldwide; Africa, Asia and south America (India, Nepal, Tanzania, Brazil, Madagascar, Mozambique) MOT (mode of transmission): Inhalation (respiratory droplets) Incubation period on average is 4-8 years (1-30 years) Pathogenesis: (determined by the immune response) Brief bacteremic phase Binds to macrophages and Schwann cells immune response Clinically: Thickened lesions of skin / nodules Nerve thickening and Loss of sensation (muscle weakness, tissue /organ and nasal septum destruction, ulcers...) Disfigurement and mutilation Classification (types of leprosy) 1) Tuberculoid (Paucibacillary) leprosy o There are Few skin lesions ( less than 5 lesions) o Usually no acid fast bacilli seen in the lesions 2) Lepromatous (Multibacillary) leprosy o skin lesions ( more than 5)

10 o Many acid fast bacilli seen in lesions o More in cold areas (nose, ear, knees, elbow and buttocks) o Leonine facies = (a lion-like face) 3) Borderline leprosy Note : it is important to know whether it is a multibacillary or paucibacillary, for the selection of treatment. Diagnosis Specimens: Full thickness skin biopsy, skin scrapings and nasal smears (trivial extra: tuberculosis specimen is certainly sputum) - Acid fast staining and histological examination: Not only for diagnosis but Also for diseases classification and therapy monitoring - Molecular techniques (probing and PCR which is Promising - Culture: not available in vitro (intracellular) Grown in mice footpads, athymic mice and in Armadillo Armadillo This animal has therefore provided sufficient bacilli Treatment: - Effective treatment is available: 1) Paucibacillary Dapsone + Rifampicin 6 months 2) Multibcillary Dapsone+Rifampicin+Clofazamine 12 months Sorry for any mistake, writing micro sheets ain t that easy, I was being so sweet while writing this sweet sheet of the sweetest course of this semester, which is being taught by the super-sweet doctor

Characteristics of Mycobacterium

Characteristics of Mycobacterium Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to

More information

Mycobacterium tuberculosis. Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology

Mycobacterium tuberculosis. Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology Mycobacterium tuberculosis Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology Robert Koch 1843-1910 German physician Became famous for isolating the anthrax bacillus (1877), tuberculosis bacillus (1882)

More information

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes Medical Bacteriology- lecture 13 Mycobacterium Actinomycetes Mycobacterium tuberculosis Large, very weakly gram positive rods, Obligate aerobes, related to Actinomycetes, non spore forming, non motile

More information

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive

More information

MYCOBACTERIA. Pulmonary T.B. (infect bird)

MYCOBACTERIA. Pulmonary T.B. (infect bird) MYCOBACTERIA SPP. Reservoir Clinical Manifestation Mycobacterium tuberculosis Human Pulmonary and dissem. T.B. M. lepra Human Leprosy M. bovis Human & cattle T.B. like infection M. avium Soil, water, birds,

More information

CHAPTER 3: DEFINITION OF TERMS

CHAPTER 3: DEFINITION OF TERMS CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria

More information

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting

More information

TUBERCULOSIS. Famous victims in their intellectual prime: Chopin, Paganini, Thoreau, Keats, Elizabeth Browning, Brontës

TUBERCULOSIS. Famous victims in their intellectual prime: Chopin, Paganini, Thoreau, Keats, Elizabeth Browning, Brontës TUBERCULOSIS GENERAL Tuberculosis (TB) kills 1,700,000 annually worldwide. "The Captain of all the men of death that came to take him away was the consumption, for it was that which brought him down to

More information

Pathology of pulmonary tuberculosis. Dr: Salah Ahmed

Pathology of pulmonary tuberculosis. Dr: Salah Ahmed Pathology of pulmonary tuberculosis Dr: Salah Ahmed Is a chronic granulomatous disease, caused by Mycobacterium tuberculosis (hominis) Usually it involves lungs but may affect any organ or tissue Transmission:

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis

Communicable Disease Control Manual Chapter 4: Tuberculosis Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from

More information

Tuberculosis. By: Shefaa Q aqa

Tuberculosis. By: Shefaa Q aqa Tuberculosis By: Shefaa Q aqa Tuberculosis is a communicable chronic granulomatous disease caused by Mycobacterium tuberculosis. It usually involves the lungs but may affect any organ or tissue in the

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

MYCOBACTERIUM. Mycobacterium Tuberculosis (Mtb) nontuberculous mycobacteria (NTM) Mycobacterium lepray

MYCOBACTERIUM. Mycobacterium Tuberculosis (Mtb) nontuberculous mycobacteria (NTM) Mycobacterium lepray MYCOBACTERIUM nontuberculous mycobacteria (NTM) Mycobacterium Tuberculosis (Mtb) Mycobacterium lepray 1-tubercle bacilli are thin 2- straight rods 3- obligate aerobes 4- derive energy from the oxidation

More information

Mycobacteriology William H. Benjamin, Jr.

Mycobacteriology William H. Benjamin, Jr. Mycobacteriology William H. Benjamin, Jr. William H. Benjamin, PhD Department of Pathology UAB 1 Mycobacteria sp. Acid Fast Bacilli (AFB) Mycolic acids (C78-91) Waxes Obligate aerobes Slow growing days

More information

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB the basics. (Dr) Margaret (DHA) and John (INZ) TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2

More information

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition Pulmonary Tuberculosis Debra Mercer BSN, RN, RRT Definition Tuberculosis is a contagious bacterial infection of the lungs caused by Mycobacterium Tuberculosis (TB) Etiological Agent: Mycobacterium Tuberculosis

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 TUBERCULOSIS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY GLOBAL EMERGENCY: * Tuberculosis kills 5,000 people a day! * 2.3 million die each year!

More information

Tuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH)

Tuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 20 Tuberculosis Learning Objectives 1. Describe the biologic characteristics of the agent 2. Determine the epidemiologic characteristics

More information

Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018

Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018 Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018 1 Introduction This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine and the 2007 WHO

More information

Order: Actinomycetales. Family: Mycobactericeae. Some are parasitic to cold blooded animal, others are saprophytic in nature.

Order: Actinomycetales. Family: Mycobactericeae. Some are parasitic to cold blooded animal, others are saprophytic in nature. Order: Actinomycetales Family: Mycobactericeae They are widely distributed in nature. Few no is pathogenic for man & animal. Some are parasitic to cold blooded animal, others are saprophytic in nature.

More information

MODULE ONE" TB Basic Science" Treatment Action Group TB/HIV Advocacy Toolkit

MODULE ONE TB Basic Science Treatment Action Group TB/HIV Advocacy Toolkit MODULE ONE" TB Basic Science" Treatment Action Group TB/HIV Advocacy Toolkit Topics to be covered What is Tuberculosis? TB bacteria and what is unique about it. How is TB different from HIV? How is TB

More information

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.

More information

Tuberculosis Elimination: The Role of the Infection Preventionist

Tuberculosis Elimination: The Role of the Infection Preventionist Tuberculosis Elimination: The Role of the Infection Preventionist Preface: What Happens when Health Care Professionals are not familiar with TB? A 15 year old student was diagnosed with highly infectious

More information

Respiratory System الفريق الطبي االكاديمي

Respiratory System الفريق الطبي االكاديمي Respiratory System الفريق الطبي االكاديمي Pathology sheet 5 Tuberculosis Done by: Ahmad Al-Sahele Introduction: as we know TB is caused by mycobacterium tubercolosis; now keep in your mind another microorganism

More information

Mycobacteriaceae

Mycobacteriaceae Mycobacteriaceae 9.04.2018 1 Classification Kingdom: Bacteria Phylum: Actinobacteria Order: Actinomycetales Family: Mycobacteriaceae Genus: Mycobacterium 9.04.2018 2 The properties of Mycobacterium genus

More information

Transmission and Pathogenesis of Tuberculosis. Transmission and Pathogenesis of Tuberculosis. Mycobacteria. Introduction to the pathogen Transmission

Transmission and Pathogenesis of Tuberculosis. Transmission and Pathogenesis of Tuberculosis. Mycobacteria. Introduction to the pathogen Transmission Transmission and Pathogenesis of Tuberculosis Adithya Cattamanchi MD, MAS Assistant Professor of Medicine University of California San Francisco Slides adapted from James Watts, Phil Hopewell Transmission

More information

Transmission and Pathogenesis of Tuberculosis

Transmission and Pathogenesis of Tuberculosis Transmission and Pathogenesis of Tuberculosis Adithya Cattamanchi MD, MAS Associate Professor of Medicine University of California San Francisco Slides adapted from James Watts, Phil Hopewell Transmission

More information

Leprosy. Dr Rodney Itaki Lecturer Anatomical Pathology Discipline

Leprosy. Dr Rodney Itaki Lecturer Anatomical Pathology Discipline Leprosy Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Leprosy - Overview Slow progressive infection

More information

MO TASEM AJ Nader Alaridah

MO TASEM AJ Nader Alaridah 22 MO TASEM AJ...... Nader Alaridah Mycobacterium ** Mycobacterium is a class of Actinobacteria, which are non-spore forming, non-motile and acid-fast bacilli ( they remain stained with the red dye carbofuchsin

More information

New NICE guideline updates recommendations for diagnosing latent tuberculosis

New NICE guideline updates recommendations for diagnosing latent tuberculosis Tel: 0845 003 7782 www.nice.org.uk Ref: 2011/053 PRESS RELEASE New NICE guideline updates recommendations for diagnosing latent tuberculosis The National Institute for Health and Clinical Excellence (NICE)

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Tuberculosis Pathogenesis Lynn Horvath, MD April 3, 2012 Lynn Horvath, MD has the following disclosures to make: No conflict of interests No relevant

More information

Tuberculosis Pathogenesis

Tuberculosis Pathogenesis Tuberculosis Pathogenesis Renuka Khurana, MD, MPH May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Renuka Khurana, MD, MPH has the following disclosures

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

TUBERCULOSIS. By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi

TUBERCULOSIS. By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi TUBERCULOSIS By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi Tuberculosis Infectious, Systemic, Chronic granulomatous disease caused by mycobacterium tuberculosis DEFINITION

More information

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis (TB) Fundamentals for School Nurses Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of

More information

LESSON ASSIGNMENT. After completing this lesson, you should be able to:

LESSON ASSIGNMENT. After completing this lesson, you should be able to: LESSON ASSIGNMENT LESSON 6 Tuberculosis. TEXT ASSIGNMENT Paragraphs 6-1 through 6-11. LESSON OBJECTIVES After completing this lesson, you should be able to: 6-1. Identify the characteristics, signs/ symptoms,

More information

What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390

What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390 386 Chapter 25 In this chapter: What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390 Preventing TB 391 Working for Change 391 387 (TB)

More information

Tuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases

Tuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases Tuberculosis - clinical forms Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases 1 TB DISEASE Primary Post-primary (Secondary) Common primary forms Primary complex Tuberculosis of the intrathoracic

More information

SWABCHA Fact Sheet: Tuberculosis (TB)

SWABCHA Fact Sheet: Tuberculosis (TB) SWABCHA (TB) Text sourced from the SWABCHA Change Agent Training Guide - 2012 Introduction to TB Microscopic bacteria called Mycobacterium tuberculosis causes TB Only TB of the lungs or throat may be infectious.

More information

CHRONIC INFLAMMATION

CHRONIC INFLAMMATION CHRONIC INFLAMMATION Chronic inflammation is an inflammatory response of prolonged duration often for months, years or even indefinitely. Its prolonged course is proved by persistence of the causative

More information

Hansen s Disease. by Kameron Petok

Hansen s Disease. by Kameron Petok Hansen s Disease by Kameron Petok Disease Name and History Hansen s disease is also known as Leprosy. The microbe that causes it was first discovered by Dr. Gerhard Henrik Armauer Hansen of Norway in 1873.

More information

PEDIATRIC TB. Modified PPT from group A seminar (F)

PEDIATRIC TB. Modified PPT from group A seminar (F) PEDIATRIC TB Modified PPT from group A seminar (F) objectives the epidemiology of pediatric TB. TB Mycobacteriology. pediatric TB presentations compared to adults TB. Know the differences between, and

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

TUBERCULOSIS. Pathogenesis and Transmission

TUBERCULOSIS. Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are

More information

HISTORY TB = 25% ADULT DEATHS EGYPTIAN MUMMIES: SPINAL TB. 17 th -18th CENTURIES- URBANIZATION MID 24

HISTORY TB = 25% ADULT DEATHS EGYPTIAN MUMMIES: SPINAL TB. 17 th -18th CENTURIES- URBANIZATION MID 24 HISTORY EGYPTIAN MUMMIES: SPINAL TB 17 th -18th CENTURIES- URBANIZATION 19th CENTURY INDUSTRIALIZATION TB = 25% ADULT DEATHS GERM THEORY OF DISEASE KOCH S BACILLUS-1883 PRE-ANTIBIOTIC ERA SANATORIUM REGIMENS

More information

HISTORY TB = 25% ADULT DEATHS MID 24 PRE-ANTIBIOTIC ERA

HISTORY TB = 25% ADULT DEATHS MID 24 PRE-ANTIBIOTIC ERA PRE-ANTIBIOTIC ERA SANATORIUM REGIMENS & REST CAVITARY DISEASE & COLLAPSE THERAPY FRESH AIR, SUNSHINE-ROOFTOPS SOLARIA HISTORY EGYPTIAN MUMMIES: SPINAL TB 17 th -18th CENTURIES- URBANIZATION 19th CENTURY

More information

Tuberculosis: The Essentials

Tuberculosis: The Essentials Tuberculosis: The Essentials Kendra L. Fisher, MD, PhD THORACIC TUBERCULOSIS: THE BARE ESSENTIALS Kendra Fisher MD, FRCP (C) Department of Radiology Loma Linda University Medical Center TUBERCULOSIS ()

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis

More information

Proposed Regs.pdf

Proposed Regs.pdf Kansas Wesleyan University TB testing Policy In Compliance with Kansas Statue KSA 2009 Supp. 65-129, all Kansas Wesleyan University students who have traveled, resided in for more than three months, or

More information

All you need to know about Tuberculosis

All you need to know about Tuberculosis All you need to know about Tuberculosis What is tuberculosis? Tuberculosis is an infectious disease that usually affects the lungs. Doctors make a distinction between two kinds of tuberculosis infection:

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

HISTORY TB = 25% ADULT DEATHS PRE-ANTIBIOTIC ERA SANATORIUM REGIMENS & REST CAVITARY DISEASE & COLLAPSE THERAPY FRESH AIR, SUNSHINE-ROOFTOPS SOLARIA

HISTORY TB = 25% ADULT DEATHS PRE-ANTIBIOTIC ERA SANATORIUM REGIMENS & REST CAVITARY DISEASE & COLLAPSE THERAPY FRESH AIR, SUNSHINE-ROOFTOPS SOLARIA PRE-ANTIBIOTIC ERA SANATORIUM REGIMENS & REST CAVITARY DISEASE & COLLAPSE THERAPY FRESH AIR, SUNSHINE-ROOFTOPS SOLARIA HISTORY EGYPTIAN MUMMIES: SPINAL TB 17 th -18th CENTURIES- URBANIZATION 19th CENTURY

More information

INDUSTRIALIZATION TB = 25% ADULT DEATHS

INDUSTRIALIZATION TB = 25% ADULT DEATHS HISTORY EGYPTIAN MUMMIES: SPINAL TB 17 th -18th CENTURIES- URBANIZATION 19th CENTURY INDUSTRIALIZATION TB = 25% ADULT DEATHS 1 GERM THEORY OF DISEASE KOCH S BACILLUS-1883 PRE-ANTIBIOTIC ERA SANATORIUM

More information

Questions and Answers About

Questions and Answers About Questions and Answers About TB 2002 DEPARTMENT OF HEALTH AND HUMAN SERVICES n Questions and Answers About TB 2002 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National

More information

Northwestern Polytechnic University

Northwestern Polytechnic University Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions

More information

Variety of Names. Great White Plague

Variety of Names. Great White Plague Tuberculosis...Where youth grows pale, and spectre-thin, and dies;... You must not look at me in my dying gasp, nor breathe my passing breath... That drop of blood is my death warrant. I must die. --John

More information

Self-Study Modules on Tuberculosis

Self-Study Modules on Tuberculosis Self-Study Modules on Tuberculosis Transmission and Pathogenesis of Tube rc ulos is U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for HIV/AIDS,

More information

Descriptive Epidemiology Project: Tuberculosis in the. United States. MPH 510: Applied Epidemiology. Summer A 2014

Descriptive Epidemiology Project: Tuberculosis in the. United States. MPH 510: Applied Epidemiology. Summer A 2014 Descriptive Epidemiology Project: Tuberculosis in the United States MPH 510: Applied Epidemiology Summer A 2014 June 1, 2014 1 The white plague affected thousands upon thousands of people in the 18 th

More information

leprosy I. Keramidas M.D.

leprosy I. Keramidas M.D. leprosy I. Keramidas M.D. Presentation outline Introduction Classification Diagnosis Some general data Treatment Epidemiological data Introduction Leprosy is a chronic infectious disease caused by Mycobacterium

More information

Dermatology in Hospital Kuala Lumpur

Dermatology in Hospital Kuala Lumpur Dermatology in Hospital Kuala Lumpur Elective Prize/Project Grant - Winter 2017 Grace P Y Wong St George s University of London Dermatology in Hospital Kuala Lumpur, Malaysia Firstly, I would like to thank

More information

TB Transmission, Pathogenesis & Infection Control

TB Transmission, Pathogenesis & Infection Control TB Transmission, Pathogenesis & Infection Control Bradley Allen, MD, PhD, FACP, FIDSA. 2014 MFMER slide-1 Disclosures Medical Consultant, TB Control Program Indiana State Department of Health Past clinical

More information

Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis

Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis by R. Dayal, a G. Sirohi, a M. K. Singh, a P. P. Mathur, a B. M. Agarwal, a V. M. Katoch, b B. Joshi, b P. Singh, b and H. B. Singh

More information

Tuberculosis Part 1. Some useful truths

Tuberculosis Part 1. Some useful truths Tuberculosis Part 1 Some useful truths Tuberculosis will be dealt with in detail in chapter 9 in a few week s time when we deal with the air borne bacterial diseases and the diseases of the lower respiratory

More information

Questions and Answers About

Questions and Answers About Questions and Answers About TB 2005 DEPARTMENT OF HEALTH AND HUMAN SERVICES TB Elimination Questions and Answers About TB 2005 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention

More information

TB, BCG and other things. Chris Conlon Infectious Diseases Oxford

TB, BCG and other things. Chris Conlon Infectious Diseases Oxford TB, BCG and other things Chris Conlon Infectious Diseases Oxford Epidemiology Latent TB IGRA BCG >50/100000

More information

Contracts Carla Chee, MHS May 8, 2012

Contracts Carla Chee, MHS May 8, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Contracts Carla Chee, MHS May 8, 2012 Carla Chee, MHS has the following disclosures to make: No conflict of interests No relevant

More information

TB in Children. Rene De Gama Block 10 Lectures 2012

TB in Children. Rene De Gama Block 10 Lectures 2012 TB in Children Rene De Gama Block 10 Lectures 2012 Contents Epidemiology Transmission and pathogenesis Diagnosis of TB TB and HIV Management Epidemiology The year 2000 8.3 million new TB cases diagnosed

More information

Symptoms Latent TB Active TB

Symptoms Latent TB Active TB 1 Tuberculosis Tuberculosis (TB) is a disease that can spread through the air. It is caused by a bacterium called Mycobacterium tuberculosis. It usually affect the lungs. However, it can also affect other

More information

What is tuberculosis? What causes tuberculosis?

What is tuberculosis? What causes tuberculosis? What is tuberculosis? What causes tuberculosis? Last updated: Thursday 4 September 2014 Tuberculosis Infectious Diseases / Bacteria / Viruses Respiratory / Asthma Some may see Tuberculosis as a historical

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018 Antimycobacterial drugs Dr.Naza M.Ali lec 14-15 6 Dec 2018 About one-third of the world s population is infected with M. tuberculosis With 30 million people having active disease. Worldwide, 9 million

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Tuberculosis prevention in immunodepressed patients M. Carmen Fariñas Álvarez Infectious Diseases.H.U.Marqués de Valdecilla University of Cantabria, Spain DISCLOSURES I have no potential conflicts with

More information

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed

More information

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally

More information

TB Intensive San Antonio, Texas December 1-3, 2010

TB Intensive San Antonio, Texas December 1-3, 2010 TB Intensive San Antonio, Texas December 1-3, 2010 TB Pathogenesis and Transmission Lynn Horvath, MD; TCID December 1, 2010 Tuberculosis Pathogenesis Lynn L. Horvath, MD, FACP, FIDSA Associate Professor

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

56% of these were in south east Asia and west pacific region.

56% of these were in south east Asia and west pacific region. Tuberc ulosis Dr. ASAAD FARHAN ASSIST. PROF.PEDS. Learning objectives epidemiology Tuberculosis remains worlds deadliest communicable disease. TB is present in all regions of the world. WHO estimates that

More information

"GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES"

GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES MAJOR PROGRAM POINTS "GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES" Training For THE CDC "TUBERCULOSIS PREVENTION GUIDELINES" "Quality Safety and Health Products, for Today...and Tomorrow"

More information

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014 What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks

More information

In the lungs, the organisms are taken up by macrophages and carried to lymph nodes. State one characteristic symptom of TB other than coughing.

In the lungs, the organisms are taken up by macrophages and carried to lymph nodes. State one characteristic symptom of TB other than coughing. 1 Tuberculosis (TB) kills approximately three million people every year. Droplets containing the organisms that cause TB are released into the air when a person suffering from TB coughs. Transmission of

More information

Currently, there are about 15 million TB patients including 11 million of working age.

Currently, there are about 15 million TB patients including 11 million of working age. Currently, there are about 15 million TB patients including 11 million of working age. The vast majority of infected people (90%) the disease does not progress. Predicted by WHO in the next twenty years

More information

"GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES"

GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES MAJOR PROGRAM POINTS "GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES" Training For THE CDC "TUBERCULOSIS PREVENTION GUIDELINES" "Quality Safety and Health Products, for Today...and Tomorrow" Outline

More information

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats Tuberculosis Facts Below are frequently asked questions about TB, and their answers. If you have additional questions you may contact the City of Ennis Department of Health Services at 972-875-1234 or

More information

Leprosy. Mycobacteriumleprae

Leprosy. Mycobacteriumleprae Leprosy Mycobacteriumleprae Quick Reference Environment: human, mice, nine-banded armadillo Microorganism: Gram + rod Spore former: NO Motile: NO Susceptibility: anyone Communicability: infectious Exposure:

More information

INTENSIFIED TB CASE FINDING

INTENSIFIED TB CASE FINDING INTENSIFIED TB CASE FINDING My friends call me Intensified Case Finding (ICF) I undertake regularly screening all people with, or at high risk of HIV, for symptoms of TB in health care facilities, communities

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

Chapter 7 Tuberculosis (TB)

Chapter 7 Tuberculosis (TB) Chapter 7 Tuberculosis (TB) TB infection vs. TB disease Information about TB TB skin testing Active TB disease TB risk factors Role of Peel Public Health in TB prevention and control Environmental and

More information

TB: A Supplement to GP CLINICS

TB: A Supplement to GP CLINICS TB: A Supplement to GP CLINICS Chapter 10: Childhood Tuberculosis: Q&A For Primary Care Physicians Author: Madhukar Pai, MD, PhD Author and Series Editor What is Childhood TB and who is at risk? India

More information

Interpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation.

Interpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation. Diagnostic Evaluation Medical Evaluation & CXR Interpretation University of Michigan TB Consultant Washtenaw County Medical history Physical examination Testing for TB exposure (previously covered) Radiologic

More information

Core Curriculum on Tuberculosis: What the Clinician Should Know

Core Curriculum on Tuberculosis: What the Clinician Should Know Core Curriculum on Tuberculosis: What the Clinician Should Know Sixth Edition 2013 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination 1 Chapters

More information

In the Name of God, Most Gracious, Most Merciful

In the Name of God, Most Gracious, Most Merciful In the Name of God, Most Gracious, Most Merciful Last lecture the doctor began discussing Brucella...In this lecture he continued and repeated some information which I ll mention anyway! Brucella : Brucella

More information

Mycobacteria and fungal infections of the respiratory tract

Mycobacteria and fungal infections of the respiratory tract Before you start: You must read the slides! The Dr. did not bother to explain them all Mycobacteria and fungal infections of the respiratory tract - TB is a global problem that the WHO is trying to combat.

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

#114 - Tuberculosis Update [1]

#114 - Tuberculosis Update [1] Published on Excellence In Learning (https://excellenceinlearning.net) Home > #114 - Tuberculosis Update #114 - Tuberculosis Update [1] Please login [2] or register [3] to take this course. $8.00 Course

More information

Management of Pediatric Tuberculosis in New Jersey

Management of Pediatric Tuberculosis in New Jersey Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis

More information

Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013

Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013 Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013 Michelle Mesaros RN BScN Nash Dhalla RN BScN BC Center for Disease Control TB and Infection Control WHAT IS TB? TB Statistics (2011)

More information